InternationalUSRemember you can easily switch between MIP US and MIP International at any time

General Court upholds Lundbeck pay-for-delay fine

James Nurton, London

Fines of nearly €150 million imposed on pharmaceutical company Lundbeck and a number of generic rivals by the European Commission have been upheld by the EU General Court. The Court's decisions are the first to find that pay-for-delay agreements breach EU antitrust rules

The cases concerned agreements between Lundbeck and four generic companies - Generics UK, Arrow, Alpharma and Ranbaxy. 

The agreements all provided that Lundbeck would pay the generic companies not to produce competing versions of its antidepressant drug citalopram (branded as...

Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

Most read articles

Latest Country Updates